Skip to main content

The Clinical Haematology Department at the Jules Bordet Institute specialises in determining and treating malignant haemopathies (blood cancers). 
The Jules Bordet Institute is committed to treating these diseases with the aim of providing the patient with individualised care of the highest quality in terms of treatment and support.

In addition to treating malignant haemopathies, the Institute is also engaged in treating adolescents and young adults (AYAs) and  rare haematological cancers while developing innovative and complex techniques and therapies, including   cell therapies.

The Institute’s mission covers 3 main university fields: clinical, research and teaching. Multidisciplinarity, in both its diagnostic and therapeutic approaches, forms an inherent part of all decisions concerning the patient.  

Research projects

Some examples of clinical and translational research

Project 1

Protocoles de recherche clinique académiques et pharmaceutiques
  • Project leaders : Drs M. Maerevoet and N. Meuleman
  • Funding : Fonds Ariane, Pharma

Project 2

Interculturality and Transplantation  
  • Project leaders : Sandra Michiels, Patrick Crombez
  • Collaboration : MASCC (International, Prof Klastersky)
  • Funding : «Association Jules Bordet» / BHS / Fondation Kisane

Project 3

Role of radio-immunotherapy in myeloma

Project 4

  • Project leader : Alice Wolfromm

Our team

  • Hematologists
    • Pr Nathalie MEULEMAN, Head of Department
    • Pr Virginie DE WILDE, Head of Department (associated)
    • Dr Fabio ANDREOZZI
    • Pr Samantha BENGHIAT
    • Dr Sarah BUNTINX
    • Dr Martin COLARD
    • Dr Julie DALLEMAGNE
    • Pr Philippe LEWALLE
    • Dr Marie MAEREVOET
    • Dr Fulvio MASSARO
    • Dr Ornella RIZZO
    • Dr Adriano SALAROLI
    • Dr Chloé SPILLEBOUDT
    • Dr Marie VERCRUYSSEN
    • Pr Sebastian WITTNEBEL
    • Dr Alice WOLFROMM
  • Consultants
    • Pr Dominique BRON
    • Dr Nicolas CILLA
    • Dr Marine DE VICQ
    • Dr Françoise LE MOINE
    • Pr Serge MOTTE
    • Dr Daphné PAPAZOGLOU



 Scientific publications

Linking clinical and population-based data in older patients with cancer in Belgium: Feasibility and clinical outcomes.

Authors : Depoorter V, Vanschoenbeek K, Decoster L, De Schutter H, Debruyne PR, De Groof I, Bron D, Cornélis F, Luce S, Focan C, Verschaeve V, Debugne G, Langenaeken C, Van den Bulck H, Goeminne JC, Teurfs W, Jerusalem G, Schrijvers D, Petit B, Rasschaert M, Praet JP, Vandenborre K, Milisen K, Flamaing J, Kenis C, Verdoodt F, Wildiers H
Year : 2023
Journal : J Geriatr Oncol
Pages : 101428

Potential of Mesenchymal Stromal Cell-Derived Extracellular Vesicles as Natural Nanocarriers: Concise Review.

Authors : Draguet F, Bouland C, Dubois N, Bron D, Meuleman N, Stamatopoulos B, Lagneaux L
Year : 2023
Journal : Pharmaceutics
Volume : 15

Incidence of falls and fall-related injuries and their predictive factors in frail older persons with cancer: a multicenter study.

Authors : Kenis C, Decoster L, Flamaing J, Debruyne PR, De Groof I, Focan C, Cornélis F, Verschaeve V, Bachmann C, Bron D, Van den Bulck H, Schrijvers D, Langenaeken C, Specenier P, Jerusalem G, Praet JP, De Cock J, Lobelle JP, Wildiers H, Milisen K
Year : 2022
Journal : BMC Geriatr
Volume : 22
Pages : 877

Ciltacabtagene Autoleucel for Patients With Triple-class Exposed Multiple Myeloma: Adjusted Comparison of CARTITUDE-1 Patient Outcomes Versus Real-world Clinical Practice.

Authors : Delforge M, Vekemans MC, Depaus J, Meuleman N, Van de Velde A, Vande Broek I, Vandervennet S, Van Hoorenbeeck S, Moorkens E, Strens D, Diels J, Ghilotti F, Haefliger B, Dalhuisen S, Deraedt W, Anguille S
Year : 2022
Journal : Hemasphere
Volume : 6
Pages : e813

Functional status in older patients with cancer and a frailty risk profile: A multicenter observational study.

Authors : Meert G, Kenis C, Milisen K, Debruyne PR, De Groof I, Focan C, Cornélis F, Verschaeve V, Bachmann C, Bron D, Den Bulck HV, Schrijvers D, Langenaeken C, Specenier P, Jerusalem G, Praet JP, Lobelle JP, Flamaing J, Wildiers H, Decoster L
Year : 2022
Journal : J Geriatr Oncol
Volume : 13
Pages : 1162-1171